Скачать или смотреть ProMedUSA+AtmosAir BiPolar Ionization- How it works, Expert opinions, Covid-19 Test results

ProMedUSA is your local AtmosAir dealer.
AtmosAir products provide indoor air quality solutions that suppress airborne and surface microbials and pathogens, including coronavirus, other viruses, bacteria and mould, and reduce odours as well as unhealthy and irritating volatile organic compounds (VOCs).
AtmosAir Solutions' tested and proven air purification technology is a continuous disinfectant, removing airborne and surface contaminants from indoor spaces.
According to recent tests performed by Microchem Laboratory, one of the world's preeminent laboratories for testing sanitizing products registered by the EPA and FDA, the presence of coronavirus was reduced by 99.92% within 30 minutes of exposure to AtmosAir's BPI technology.
AtmosAir’s technology proactively emits bi-polar ions that seek, attack and neutralize coronavirus. These results demonstrate that AtmosAir's public health solution is effective in stopping the spread of pathogens and contaminants.
AtmosAir's patented bi-polar ionization (abbreviated as "BPI") technology compliments the existing solutions commonly used in the air conditioning and air handling industry. In addition to deterring coronavirus, other key advantages of BPI include:
• Disinfects air by producing and distributing a controlled amount of positive and negative air ions, which interact with oppositely charged elements.
• Bi-polar ionization process allows for air cleaning to occur within the desired space treating a larger volume of air within the breathing range.
• Effective against bacteria, spores, VOC compounds and particles by treating the source of contamination.
• Can be incorporated into central HVAC systems or used as stand-alone units in a cost-effective, energy-efficient and environmentally sustainable manner.
• Requires minimal maintenance once every 2 years to replace worn bi-polar ionisation tubes.